A public offering of over 11 million shares of common stock has been announced by British Columbia-based cardiovascular medtech company Neovasc in hopes of raising $4.25 million in net proceeds. The proceeds will be used as working capital, as well as for product development and general corporate purposes.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.